‘Medicine Miles’ Becoming a Concern for European Patients

Exploration shows the origin of medications will become more crucial AMSTERDAM, October 04, 2021–(Organization WIRE)–The…

‘Medicine Miles’ Becoming a Concern for European Patients

Exploration shows the origin of medications will become more crucial

AMSTERDAM, October 04, 2021–(Organization WIRE)–The pandemic has brought on a higher desire amongst clients about Europe’s part in medicine production.

New analysis just discovered clearly show that 7 in 10 patients now want to know the place their medicine are built as the pandemic has exposed weaknesses in the increasing focus of necessary medication output overseas.

The review discovered the large greater part (84{6654ab549aea683dfb163c18f2e935eca578ab77e61967d7a8b1932c06e74d91}) of patients want their governing administration to support pharmaceutical manufacturing investments in their location to prevent over-dependencies on international locations outside the house of Europe.

The research questioned thousands of European individuals who rely on standard medication for long-term ailments and identified 7 in 10 (71{6654ab549aea683dfb163c18f2e935eca578ab77e61967d7a8b1932c06e74d91}) are fascinated in knowing Europe continues to be as competitive as other areas.


The results place to the want to rebalance the international pharmaceutical worth chain to ensure every region all-around the environment has reliable obtain to critical medications.

It arrives as the COVID-19 pandemic has highlighted troubles with world supply chains brought on by the producing of active pharmaceutical components currently being clustered in Asia. Whilst Europe continues to be strong in generating concluded medications it has lost its management posture in active pharmaceutical component manufacturing in the off-patent generics sector – specially for vital medicines like paracetamol – opening up strategic vulnerabilities.

The study by Teva Prescribed drugs sought viewpoints from 3,000 individuals aged above 25 from France, Germany, The Netherlands, Spain, Croatia and the Czech Republic. All members experienced from one or a lot more long-term conditions including Alzheimer’s, arthritis, asthma, most cancers, cardiovascular ailment, COPD, despair, diabetes, heart illness, and migraine – necessitating common treatment.

WAKE-UP Contact

Richard Daniell, Govt Vice President for Teva in Europe, explained: “The jolt of the pandemic acts as a wake-up phone that the increasing imbalance of the global pharmaceutical price chain cannot keep on.

Individuals now truly care about in which their medicines are built. In the very same way that “foods miles” have turn out to be a vital worry between individuals in latest years, sufferers now want to know additional about “medicine miles” when it arrives to the treatment options they choose.

Europe’s unhealthy more than-reliance on overseas lively pharmaceutical ingredient production has been exposed by the closure of factories and borders. But nationalistic techniques really don’t operate in such a extremely linked and interdependent place as modern-day medicine source. Europe have to alter its procedures to new financial and technological realities, even though increasing its competitiveness and geopolitical posture by remaining open and attracting investments.

“Teva supports 200 million clients each working day, preserving Europe’s drugs cabinet stocked, as just one of the premier of suppliers to European healthcare techniques. Right now we make 95{6654ab549aea683dfb163c18f2e935eca578ab77e61967d7a8b1932c06e74d91} of Teva medicines in Europe, supported by our international supply line. And we are investing close to a billion euros in production services across Europe. What’s enlightening about this study is that sufferers are waking up to these problems and demanding improve.

“The race to the most affordable-rate generic has to prevent and Europe’s rather inflexible and aged fashioned regulatory regime need to be modernized to preserve Europe in the race to appeal to pharmaceutical investments to generate important APIs and generic medicines.

“With the needs of individuals at its coronary heart, a new equilibrium also stands to boost Europe’s resilience as properly as delivering a substantial economic contribution to the region. There is an prospect to seize this watershed second and construct a much better ecosystem in which a stronger pharmaceutical manufacturing presence in Europe can complement the rest of the international provide chain.”


The research exhibits that European people take into account this kind of commitments are very important for a sustainable future.

Almost 3-quarters (73{6654ab549aea683dfb163c18f2e935eca578ab77e61967d7a8b1932c06e74d91}) of persons think the pharmaceutical marketplace is strategically vital for Europe as we go out of the pandemic, simply because it can make certain steadiness and trustworthiness of medication supplies.

Nearly two-thirds (61{6654ab549aea683dfb163c18f2e935eca578ab77e61967d7a8b1932c06e74d91}) assume drugs production in the area is critical to safeguard European health care techniques, and around the very same amount (59{6654ab549aea683dfb163c18f2e935eca578ab77e61967d7a8b1932c06e74d91}) see it as very important to secure Europe’s autonomy and sovereignty about vital drugs.

Economic Affect

The examine observed 85{6654ab549aea683dfb163c18f2e935eca578ab77e61967d7a8b1932c06e74d91} of patients see the pharmaceutical sector as important to driving financial restoration as we emerge from the depths of the pandemic.

Men and women cited work development and supporting the regional economic climate as the top gain for advertising and marketing drugs manufacture in Europe (57{6654ab549aea683dfb163c18f2e935eca578ab77e61967d7a8b1932c06e74d91}), closely followed by a motivation for far better accessibility to important drugs and lowering reliance on overseas provide (56{6654ab549aea683dfb163c18f2e935eca578ab77e61967d7a8b1932c06e74d91}).

Furthermore, more than 70{6654ab549aea683dfb163c18f2e935eca578ab77e61967d7a8b1932c06e74d91} of European sufferers want to see Europe stay as competitive as other regions and count on their federal government to take motion to aid this.

ENVIRONMENTAL Considerations

The setting was a top rated worry amid patients with 65{6654ab549aea683dfb163c18f2e935eca578ab77e61967d7a8b1932c06e74d91} demanding that their medicines be built in way that’s environmentally sustainable.

In addition, extra than half (55{6654ab549aea683dfb163c18f2e935eca578ab77e61967d7a8b1932c06e74d91}) of people see the advantages of prescription drugs manufactured in Europe linked to the probable of transport reduction-similar environmental impact. And about a third (35{6654ab549aea683dfb163c18f2e935eca578ab77e61967d7a8b1932c06e74d91}) of people assume Europe ensures greener creation and respect for environmental laws than abroad manufacturing.


About Teva and Its Impression in Europe

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to boost people’s life for 120 Several years. We are a worldwide chief in generic and specialty medicines with a portfolio consisting of more than 3,500 products in virtually every single therapeutic region.

Around 200 million persons all around the world choose a Teva drugs every day, are served by one particular of the largest and most intricate supply chains in the pharmaceutical business. Alongside with our established existence in generics, we have sizeable ground breaking study and functions supporting our expanding portfolio of specialty and biopharmaceutical merchandise. Teva operated 32 producing and research and advancement amenities across Europe in 2020.

In Europe, Teva’s local buys and payroll across the 9 important marketplaces supported virtually 105,000 work opportunities, contributed $29.5 billion (€25.8 billion) to financial output, and created $5.6 billion (€4.9 billion) in labor revenue. Teva’s generic medicines saved healthcare systems throughout 9 European nations $9.6 billion (€8.4 billion) in 2020. Study extra about Teva and its Financial Influence .

Check out supply edition on businesswire.com: https://www.businesswire.com/information/home/20211003005048/en/


Fiona Cohen, Senior Director, Company Communications, Teva EU
+ 31 6 2008 2545